Sino Biopharmaceutical Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
16.88 | -28.02 | -160.26% | 31.75 | -46.82% |
| P/S |
|
2.05 | 54.93 | -96.27% |
|
|
| P/BV |
|
1.3 | 3.04 | -57.34% |
|
|
| P/FCF |
|
26.12 | 15.64 | 67.01% |
|
|
| Ev/Ebitda |
|
9.71 | 29.1 | -66.63% |
|
|
| Ev/S |
|
2.06 | -0.5185 | -496.35% |
|
|
| Ev/FCF |
|
11.37 | -6.42 | -277.09% |
|
|
| E/P |
|
0.0257 | 0.0191 | 34.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
21.16 | -262.37 | -108.06% | 33.23 | -36.33% |
| ROE |
|
10.37 | -5.11 | -303.02% |
|
|
| ROA |
|
5.02 | 0.2787 | 1699.36% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
12.12 | -266.12 | -104.55% |
|
|
| ROCE |
|
11.35 | 0.7482 | 1416.91% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.71 | 0.5857 | 191.23% | 1.51 | +12.96% |
| Nеt Debt/Ebitda |
|
0.0373 | -1.06 | -103.51% |
|
|
| Debt/Ratio |
|
0.1496 | 0.1351 | 10.72% |
|
|
| Debt/Equity |
|
0.5293 | 0.8667 | -38.93% |
|
|
| Debt/Net Income |
|
2.98 | 2.28 | 30.84% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.88/10
|
1.15 | 1.61 | -28.5% | 2.11 | -45.54% |
| Number of years of dividend growth |
|
1 | 1.46 | -31.34% | ||
| DSI |
|
0.7857 | 0.5532 | 42.04% |
|
|
| Average dividend growth |
|
12.09 | 2.92 | 313.85% |
|
|
| Average percentage for 5 years |
|
2.11 | 3.28 | -35.55% |
|
|
| Average percentage for payments |
|
50.06 | 34.24 | 46.19% |
|
|
| Difference from average difference in sector |
|
-0.4584 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
2/10
|
11.47 | 13.37 | -14.21% | ||
| Growth impulse Ebitda in 5 years |
|
-6.36 | -25.45 | -75.01% | ||
| Growth impulse Net Income in 5 years |
|
15.48 | 21.87 | -29.22% | ||
| Growth impulse FCF in 5 years |
|
37.62 | 144.65 | -73.99% | ||
| Growth impulse EPS in 5 years |
|
9.19 | -78.86 | -111.65% |
IP Score
5.44/10
